Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis

View ORCID ProfileJames B. Badenoch, View ORCID ProfileEmma R. Rengasamy, View ORCID ProfileCameron J. Watson, View ORCID ProfileKatrin Jansen, View ORCID ProfileStuti Chakraborty, View ORCID ProfileRitika D. Sundaram, View ORCID ProfileDanish Hafeez, View ORCID ProfileElla Burchill, Aman Saini, View ORCID ProfileLucretia Thomas, View ORCID ProfileBenjamin Cross, View ORCID ProfileCamille K. Hunt, Isabella Conti, Sylvia Ralovska, View ORCID ProfileZain Hussain, Matthew Butler, View ORCID ProfileThomas A. Pollak, View ORCID ProfileIvan Koychev, View ORCID ProfileBenedict D. Michael, View ORCID ProfileHeinz Holling, View ORCID ProfileTimothy R. Nicholson, View ORCID ProfileJonathan P. Rogers, View ORCID ProfileAlasdair G. Rooney, for the SARS-CoV-Neuro Collaboration
doi: https://doi.org/10.1101/2021.04.30.21256413
James B. Badenoch
1Medical School, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James B. Badenoch
Emma R. Rengasamy
2Cwm Taf Morgannwg University Health Board, Wales, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emma R. Rengasamy
Cameron J. Watson
3Preventive Neurology Unit, Queen Mary University of London, London, UK. Barts Health NHS Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cameron J. Watson
Katrin Jansen
4Department of Psychology, University of Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katrin Jansen
Stuti Chakraborty
5Department of Physical Medicine and Rehabilitation, Christian Medical College and Hospital, Vellore, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stuti Chakraborty
Ritika D. Sundaram
6School of Medicine, University of Glasgow, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ritika D. Sundaram
Danish Hafeez
7School of Medical Sciences, University of Manchester, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Danish Hafeez
Ella Burchill
8Faculty of Life Sciences and Medicine, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ella Burchill
Aman Saini
9University College London Medical School, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucretia Thomas
10University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lucretia Thomas
Benjamin Cross
11East Lancashire Hospitals NHS Trust, Blackburn, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Benjamin Cross
Camille K. Hunt
12Clinical Trials Group, Division of Neurology, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, B.C., Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Camille K. Hunt
Isabella Conti
13School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvia Ralovska
14Department of Neurology, Psychiatry, Physiotherapy and Rehabilitation, Preventive Medicine, and Public Health, Sofia University “St. Kliment Ohridski”.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zain Hussain
15School of Medicine, University of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zain Hussain
Matthew Butler
16Institute of Psychiatry, Psychology and Neuroscience, King’s College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas A. Pollak
17Institute of Psychiatry, Psychology and Neuroscience, King’s College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas A. Pollak
Ivan Koychev
18MRCPsych. Department of Psychiatry, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ivan Koychev
Benedict D. Michael
19Institute for Infection, Veterinary, and Ecological Sciences, University of Liverpool, UK; NIHR HPRU for Emerging and Zoonotic Infection, Liverpool, UK; The Walton Centre NHS Foundation Trust, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Benedict D. Michael
Heinz Holling
20Department of Psychology, University of Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heinz Holling
Timothy R. Nicholson
21Institute of Psychiatry, Psychology and Neuroscience, King’s College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Timothy R. Nicholson
Jonathan P. Rogers
22Division of Psychiatry, University College London, London, UK; South London and Maudsley NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan P. Rogers
Alasdair G. Rooney
23Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK; The Robert Fergusson Unit, Royal Edinburgh Hospital, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alasdair G. Rooney
  • For correspondence: ally.rooney@ed.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

SUMMARY

Background The nature and extent of persistent neuropsychiatric symptoms after COVID-19 are not established. To help inform mental health service planning in the pandemic recovery phase, we systematically determined the prevalence of neuropsychiatric symptoms in survivors of COVID-19.

Methods For this pre-registered systematic review and meta-analysis (PROSPERO ID CRD42021239750) we searched PubMed, EMBASE, CINAHL and PsycINFO to 20th February 2021, plus our own curated database. We included peer-reviewed studies reporting neuropsychiatric symptoms at post-acute or later time-points after COVID-19 infection, and in control groups where available. For each study a minimum of two authors extracted summary data. For each symptom we calculated a primary pooled prevalence using generalised linear mixed models. Heterogeneity was measured with I2. Subgroup analyses were conducted for COVID-19 hospitalisation, severity, and duration of follow-up.

Findings From 2,844 unique titles we included 51 studies (n=18,917 patients). The mean duration of follow-up after COVID-19 was 77 days (range 14-182 days). Study quality was generally moderate. The most frequent neuropsychiatric symptom was sleep disturbance (pooled prevalence=27·4% [95%CI 21·4- 34·4%]), followed by fatigue (24·4% [17·5-32·9%]), objective cognitive impairment (20·2% [10·3-35·7%]), anxiety (19·1%[13·3-26·8%]), and post-traumatic stress (15·7% [9·9-24·1%]). Only two studies reported symptoms in control groups, both reporting higher frequencies in Covid-19 survivors versus controls. Between-study heterogeneity was high (I2=79·6%-98·6%). There was little or no evidence of differential symptom prevalence based on hospitalisation status, severity, or follow-up duration.

Interpretation Neuropsychiatric symptoms are common and persistent after recovery from COVID-19. The literature on longer-term consequences is still maturing, but indicates a particularly high frequency of insomnia, fatigue, cognitive impairment, and anxiety disorders in the first six months after infection.

Funding JPR is supported by the Wellcome Trust (102186/B/13/Z).

IK is funded through the NIHR (Oxford Health Biomedical Research Facility, Development and Skills Enhancement Award) and the Medical Research Council (Dementias Platform UK and Deep and Frequent Phenotyping study project grants).

HH is funded by the German Research Foundation (DFG, Grant: HO 1286/16-1). The funders played no role in the design, analysis or decision to publish.

Evidence before this study Neuropsychiatric symptoms like cognitive impairment, fatigue, insomnia, depression and anxiety can be highly disabling. Recently there has been increasing awareness of persistent neuropsychiatric symptoms after COVID-19 infection, but a systematic synthesis of these symptoms is not available. In this review we searched five databases up to 20th February 2021, to establish the pooled prevalence of individual neuropsychiatric symptoms up to six months after COVID-19.

Added value of this study This study establishes which of a range of neuropsychiatric symptoms are the most common after COVID-19. We found high rates in general, with little convincing evidence that these symptoms lessen in frequency during the follow-up periods studied.

Implications Persistent neuropsychiatric symptoms are common and appear to be limited neither to the post-acute phase, nor to recovery only from severe COVID-19. Our results imply that health services should plan for high rates of requirement for multidisciplinary services (including neurological, neuropsychiatric and psychological management) as populations recover from the COVID-19 pandemic.

Competing Interest Statement

JPR held one advisory meeting with representatives from Promentis Pharmaceuticals regarding drug development. No payment was made. JPR received payment from Alberta Psychiatric Association for lecturing at the Annual Scientific Conference. IK receives a contribution towards his salary from the Medical Research Council (Dementias Platform UK grant), NIHR Oxford Health Biomedical Research Centre, NIHR Development and Skills Enhancement award. IK has received the following grants: Medical Research Council Deep and Frequent Phenotyping study project grant, Oxford Global Challenges Research Fund project grant, MRC-NIH Partnership in Neurodegeneration award. IK has received consulting fees from Mantrah Ltd, Sharp Tx Ltd, Cognetivity Ltd. He has served as an advisory board member and has stocks options in Mantrah Ltd and Sharp Tx Ltd.

Clinical Protocols

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=239750

Funding Statement

JPR is supported by the Wellcome Trust (102186/B/13/Z). IK is funded through the NIHR (Oxford Health Biomedical Research Facility, Development and Skills Enhancement Award) and the Medical Research Council (Dementias Platform UK and Deep and Frequent Phenotyping study project grants). HH is funded by the German Research Foundation (DFG, Grant: HO 1286/16-1). The funders played no role in the design, analysis or decision to publish.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A systematic review

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Our full R code, and data, can be made available on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted May 04, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis
James B. Badenoch, Emma R. Rengasamy, Cameron J. Watson, Katrin Jansen, Stuti Chakraborty, Ritika D. Sundaram, Danish Hafeez, Ella Burchill, Aman Saini, Lucretia Thomas, Benjamin Cross, Camille K. Hunt, Isabella Conti, Sylvia Ralovska, Zain Hussain, Matthew Butler, Thomas A. Pollak, Ivan Koychev, Benedict D. Michael, Heinz Holling, Timothy R. Nicholson, Jonathan P. Rogers, Alasdair G. Rooney, for the SARS-CoV-Neuro Collaboration
medRxiv 2021.04.30.21256413; doi: https://doi.org/10.1101/2021.04.30.21256413
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis
James B. Badenoch, Emma R. Rengasamy, Cameron J. Watson, Katrin Jansen, Stuti Chakraborty, Ritika D. Sundaram, Danish Hafeez, Ella Burchill, Aman Saini, Lucretia Thomas, Benjamin Cross, Camille K. Hunt, Isabella Conti, Sylvia Ralovska, Zain Hussain, Matthew Butler, Thomas A. Pollak, Ivan Koychev, Benedict D. Michael, Heinz Holling, Timothy R. Nicholson, Jonathan P. Rogers, Alasdair G. Rooney, for the SARS-CoV-Neuro Collaboration
medRxiv 2021.04.30.21256413; doi: https://doi.org/10.1101/2021.04.30.21256413

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (171)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8794)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (493)
  • Hematology (207)
  • HIV/AIDS (396)
  • Infectious Diseases (except HIV/AIDS) (10575)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1762)
  • Nursing (104)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (966)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1846)
  • Public and Global Health (3992)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)